Influenza Hemagglutinin (HA) Peptide: Precision Tag for Protein Purification and Detection

Executive Summary: The Influenza Hemagglutinin (HA) Peptide is a synthetic, nine-residue tag (YPYDVPDYA) derived from the influenza virus hemagglutinin protein, widely adopted for protein detection, purification, and interaction studies (APExBIO). Its high-affinity interaction with Anti-HA antibodies enables robust immunoprecipitation and elution workflows in molecular biology (Wei et al., 2021). The peptide exhibits excellent solubility in water (≥46.2 mg/mL), ethanol (≥100.4 mg/mL), and DMSO (≥55.1 mg/mL), supporting versatile buffer systems. High purity (>98%) is routinely validated by HPLC and mass spectrometry. Limitations include lack of applicability for non-epitope-tagged proteins and sensitivity to storage conditions.

Biological Rationale

Peptide tags are essential tools in molecular biology for the purification and detection of recombinant proteins. The HA tag, originating from the human influenza virus hemagglutinin protein, is a well-characterized epitope recognized by specific monoclonal antibodies (Wei et al., 2021). This tag is routinely fused to proteins of interest at the N- or C-terminus via genetic engineering. The HA tag sequence (YPYDVPDYA) does not interfere with protein folding or function in most contexts (More: Mechanistic Insight...). Compared to larger affinity tags, the HA peptide minimally perturbs native protein structure and cellular localization, making it preferred for sensitive applications such as protein-protein interaction mapping and co-immunoprecipitation (Co-IP). Exosome biology, notably the sorting and trafficking of membrane proteins like EGFR, has been studied using HA-tagged constructs to elucidate cellular pathways (Wei et al., 2021). This article provides an updated synthesis of the molecular rationale for HA peptide use, extending prior discussions by focusing on practical benchmarks and integration workflows (cf. Precision Tag for Mechanistic Studies).

Mechanism of Action of Influenza Hemagglutinin (HA) Peptide

The HA peptide functions as an epitope tag recognized by Anti-HA monoclonal antibodies, typically clone 12CA5 or 3F10. Upon expression as an HA fusion protein, the tag is accessible at the protein terminus or within loops. During immunoprecipitation assays, Anti-HA antibodies conjugated to beads selectively bind HA-tagged proteins in complex lysates (Wei et al., 2021). The synthetic Influenza Hemagglutinin (HA) Peptide (A6004) is added in excess, competitively displacing the HA-tagged protein from the antibody and enabling specific elution (cf. Optimizing Tag-Based Elution). This competitive binding is highly sequence-specific and does not cross-react with unrelated protein tags. The mechanism is robust across diverse buffer compositions, enabled by the peptide’s high solubility parameters.

Evidence & Benchmarks

• HA peptide (YPYDVPDYA) enables specific immunoprecipitation and elution of tagged proteins in mammalian cell lysates, as demonstrated in exosome pathway studies (Wei et al., 2021, DOI).
• Pepide solubility exceeds 46.2 mg/mL in water, 100.4 mg/mL in ethanol, and 55.1 mg/mL in DMSO, supporting high-concentration usage in diverse protocols (APExBIO).
• Purity is confirmed at >98% by both HPLC and mass spectrometry, ensuring minimal contaminant interference in sensitive detection assays (Product Certificate).
• HA tag does not interfere with the function or subcellular localization of most fusion proteins, as validated by immunofluorescence and co-immunoprecipitation controls (see Table S3, Wei et al., 2021, DOI).
• Competitive elution with synthetic HA peptide achieves >90% recovery of HA-tagged proteins in optimized protocols (A6004 datasheet, APExBIO).

Applications, Limits & Misconceptions

The Influenza Hemagglutinin (HA) Peptide is foundational in:

• Protein-protein interaction studies: Enables mapping interactomes via Co-IP and mass spectrometry (More: Mechanistic Insight).
• Protein purification: Used for specific elution of HA-tagged proteins from Anti-HA matrices (cf. Tag-Based Workflow Optimization).
• Protein detection: Facilitates Western blot, immunofluorescence, and ELISA-based detection of recombinant proteins (cf. Translational Precision).

Common Pitfalls or Misconceptions

• The HA peptide does not facilitate purification of endogenous, non-tagged proteins.
• It cannot be used for proteins whose function or structure is disrupted by N- or C-terminal fusions.
• Long-term storage of peptide solutions is not recommended; lyophilized peptide should be stored desiccated at -20°C for stability.
• Buffer conditions with extreme pH (<4 or="">9) may reduce peptide stability or antibody binding efficiency.
• Cross-reactivity with anti-HA antibodies is highly sequence-dependent; substitutions within the HA tag sequence can abrogate binding.

Workflow Integration & Parameters

The A6004 Influenza Hemagglutinin (HA) Peptide from APExBIO is delivered as a lyophilized powder with >98% purity. Reconstitute in water, DMSO, or ethanol to prepare stock solutions at concentrations up to 55.1–100.4 mg/mL, depending on the solvent. For immunoprecipitation elution, add the peptide to a final concentration of 1–2 mg/mL in the elution buffer, incubate with the Anti-HA matrix for 15–30 minutes at 4°C, and proceed with collection (product protocol). Avoid repeated freeze-thaw cycles and store aliquots desiccated at -20°C. For protein detection or competitive binding assays, titrate peptide concentrations empirically, as excessive peptide can out-compete weakly bound HA fusion proteins, lowering yield. The peptide is compatible with standard buffers (PBS, TBS, HEPES, etc.) and a wide range of detergents and protease inhibitors. This article extends previous resource discussions by providing explicit solvent handling and storage recommendations (cf. Next-Gen Epitope Tag Review).

Conclusion & Outlook

The Influenza Hemagglutinin (HA) Peptide remains a gold-standard epitope tag for protein purification and detection in molecular biology. Its competitive binding mechanism, high solubility, and certified purity support reproducible results in protein interaction and exosome studies. New applications in systems biology and translational research continue to emerge, leveraging the robust specificity of the HA tag system. Researchers are advised to select validated sources such as APExBIO for consistent quality and to observe recommended storage and handling protocols. For advanced mechanistic insight and translational applications, readers are encouraged to consult both this and related reviews for a comprehensive understanding of the HA tag landscape.